Similar articles

• Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial.

  Kastrati A, Mehilli J, von Beckerath N, Dibra A, Hausleiter J, Pache J, Schühlen H, Schmitt C, Dirschinger J, Schömig A; ISAR-DESIRE Study Investigators. Kastrati A, et al. JAMA. 2005 Jan 12;293(2):165-71. doi: 10.1001/jama.293.2.165. JAMA. 2005. PMID: 15644543 Clinical Trial.
• Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial.

  Holmes DR Jr, Teirstein P, Satler L, Sketch M, O'Malley J, Popma JJ, Kuntz RE, Fitzgerald PJ, Wang H, Caramanica E, Cohen SA; SISR Investigators. Holmes DR Jr, et al. JAMA. 2006 Mar 15;295(11):1264-73. doi: 10.1001/jama.295.11.1264. Epub 2006 Mar 12. JAMA. 2006. PMID: 16531619 Clinical Trial.
• Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial.

  Stone GW, Ellis SG, O'Shaughnessy CD, Martin SL, Satler L, McGarry T, Turco MA, Kereiakes DJ, Kelley L, Popma JJ, Russell ME; TAXUS V ISR Investigators. Stone GW, et al. JAMA. 2006 Mar 15;295(11):1253-63. doi: 10.1001/jama.295.11.1253. Epub 2006 Mar 12. JAMA. 2006. PMID: 16531618 Clinical Trial.
• Drug-eluting stents.

  García-García HM, Vaina S, Tsuchida K, Serruys PW. García-García HM, et al. Arch Cardiol Mex. 2006 Jul-Sep;76(3):297-319. Arch Cardiol Mex. 2006. PMID: 17091802 Review.
• Drug-eluting stents for in-stent restenosis and acute myocardial infarction: present data from nonrandomized studies.

  Schofer J, Bode C, Silber S. Schofer J, et al. Herz. 2004 Mar;29(2):195-200. doi: 10.1007/s00059-004-2570-8. Herz. 2004. PMID: 15057441 Review.